Jacob Grinfeld
Beckett Street
Leeds, ENG, United Kingdom
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline.
Journal: British journal of haematology
Published: September 15, 2025
Increased CXCL10 (IP-10) is associated with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models.
Journal: Experimental hematology
Published: December 08, 2023
Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Journal: British journal of haematology
Published: December 03, 2022
Socio-economic and ethnic disparities in childhood cancer survival, Yorkshire, UK.
Journal: British journal of cancer
Published: April 12, 2022
Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia.
Journal: HemaSphere
Published: January 23, 2020
Prognostic models in the myeloproliferative neoplasms.
Journal: Blood reviews
Published: December 28, 2019
Mutant Calreticulin in the Myeloproliferative Neoplasms.
Journal: HemaSphere
Published: September 26, 2019
Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat.
Journal: Experimental hematology
Published: January 23, 2019
Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
Journal: The New England journal of medicine
Published: October 11, 2018
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 29, 2018
MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling.
Journal: Leukemia
Published: October 20, 2017
Last Updated: 09/26/2026